STRATA Skin Sciences Inc. (SSKN)
NASDAQ: SSKN
· Real-Time Price · USD
1.39
-0.01 (-0.71%)
At close: Sep 17, 2025, 3:59 PM
1.39
0.00%
After-hours: Sep 17, 2025, 04:04 PM EDT
-0.71% (1D)
| Bid | 1.38 |
| Market Cap | 5.8M |
| Revenue (ttm) | 32.85M |
| Net Income (ttm) | -11.54M |
| EPS (ttm) | -2.84 |
| PE Ratio (ttm) | -0.49 |
| Forward PE | -0.99 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.45 |
| Volume | 64,961 |
| Avg. Volume (20D) | 970,883 |
| Open | 1.41 |
| Previous Close | 1.40 |
| Day's Range | 1.38 - 1.44 |
| 52-Week Range | 1.38 - 3.86 |
| Beta | 0.56 |
| Ex-Dividend Date | n/a |
About SSKN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SSKN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SSKN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsSTRATA Skin Sciences Inc. is scheduled to release its earnings on
Nov 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-33.57%
Strata Skin Sciences shares are trading lower afte...
Unlock content with
Pro Subscription
2 weeks ago
+18.91%
Strata Skin Sciences shares are trading higher after the company announced that its patent portfolio provides intellectual property and market exclusivity for combination therapies of its XTRAC excimer laser when used with JAK inhibitor
1 month ago · seekingalpha.com
STRATA Skin Sciences, Inc. (SSKN) Q2 2025 Earnings Call TranscriptSTRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Dolev Rafaeli - President, CEO & Vice-Chairman John Gillings - Principal Fina...